1. Home
  2. CGO vs SRZN Comparison

CGO vs SRZN Comparison

Compare CGO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Global Total Return Fund

CGO

Calamos Global Total Return Fund

HOLD

Current Price

$11.57

Market Cap

112.9M

Sector

Finance

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$19.32

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGO
SRZN
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.9M
117.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CGO
SRZN
Price
$11.57
$19.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.50
AVG Volume (30 Days)
34.7K
108.1K
Earning Date
01-01-0001
11-07-2025
Dividend Yield
9.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,604,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$5.90
52 Week High
$10.93
$24.94

Technical Indicators

Market Signals
Indicator
CGO
SRZN
Relative Strength Index (RSI) 57.40 46.01
Support Level $11.38 $21.03
Resistance Level $11.63 $23.42
Average True Range (ATR) 0.14 1.98
MACD 0.03 -0.52
Stochastic Oscillator 90.49 1.79

Price Performance

Historical Comparison
CGO
SRZN

About CGO Calamos Global Total Return Fund

Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: